Illness perceptions and activity limitations in chronic low back pain.

Illness perceptions and activity limitations in chronic low back pain. A component approach to innovate rehabilitation programmes for patients with chronic low back pain.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN35108886

Enrollment

135

Registered

2010-03-08

Start date

2004-12-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic non-specific low back pain (CLBP) Musculoskeletal Diseases Dorsalgia

Interventions

Patients were randomised (2:1 ratio) to 1. Cognitive treatment of illness perceptions (CTIP): 14x one-hour sessions over a maximum period of 18 weeks 2. Waiting list control: CTIP between weeks 18 and

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age 18 - 70 years 2. Non-specific low back pain with or without radiation to the leg(s) for at least 3 months 3. Current episode of back pain lasting less than 5 years 4. Activity limitations (Roland Disability Questionnaire > 3) 5. No previous multidisciplinary treatment for CLBP 6. No involvement in litigation concerning CLBP 7. Absence of serious psychological or psychiatric problems 8. No substance abuse interfering with treatment or assessment 9. Not pregnant 10. Able to fill in questionnaires without help 11. Written informed consent

Exclusion criteria

Exclusion criteria: Does not match inclusion criteria

Design outcomes

Primary

Measure	Time frame
Patient-specific activity limitations (PSFL). Clinically relevant change =18 mm, measured at 18, 36 and 52 weeks (also at 68 weeks for control group). 18 weeks is theorised to be the first time point where changes are expected.	—

Secondary

Measure	Time frame
1. Secondary outcome: General activity limitations (QBPDS), measured at 18, 36 and 52 weeks (also at 68 weeks for control group). 2. Tertiary outcome: Health care consumption (cost-diary), measured at 18, 36 and 52 weeks (also at 68 weeks for control group). 36 weeks is theorised to be the first time point where changes are expected. 3. Process measure: illness perceptions (IPQ-R), measured at timepoints 18, 36 and 52 weeks (also at 68 weeks for control group). 18 weeks is theorised to be the first time point where changes are expected.	—

Measure

Time frame

1. Secondary outcome: General activity limitations (QBPDS), measured at 18, 36 and 52 weeks (also at 68 weeks for control group). 2. Tertiary outcome: Health care consumption (cost-diary), measured at 18, 36 and 52 weeks (also at 68 weeks for control group). 36 weeks is theorised to be the first time point where changes are expected. 3. Process measure: illness perceptions (IPQ-R), measured at timepoints 18, 36 and 52 weeks (also at 68 weeks for control group). 18 weeks is theorised to be the first time point where changes are expected.

—

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026